Morello, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 1.298
EU - Europa 656
AS - Asia 288
SA - Sud America 6
OC - Oceania 3
AF - Africa 2
Totale 2.253
Nazione #
US - Stati Uniti d'America 1.287
IT - Italia 272
CN - Cina 120
UA - Ucraina 88
DE - Germania 86
HK - Hong Kong 80
FI - Finlandia 66
SG - Singapore 59
IE - Irlanda 35
GB - Regno Unito 26
CZ - Repubblica Ceca 23
SE - Svezia 20
IN - India 17
BE - Belgio 15
CA - Canada 11
FR - Francia 8
GR - Grecia 4
PL - Polonia 4
AU - Australia 3
CO - Colombia 3
NL - Olanda 3
TR - Turchia 3
BR - Brasile 2
HR - Croazia 2
RU - Federazione Russa 2
TH - Thailandia 2
AZ - Azerbaigian 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
PE - Perù 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 2.253
Città #
Fairfield 175
Chandler 110
Ashburn 105
Brescia 97
Woodbridge 86
New York 82
Hong Kong 80
Jacksonville 79
Ann Arbor 77
Seattle 76
Wilmington 73
Helsinki 62
Princeton 57
Houston 52
Cambridge 45
Beijing 42
Boardman 40
Shanghai 36
Dublin 35
Singapore 34
Brno 22
Brussels 15
Des Moines 14
Munich 14
Milan 12
Pune 12
Los Angeles 11
Barlassina 10
Nanjing 8
Bosio 7
Gorlago 7
San Diego 7
Toronto 7
Jinan 6
London 5
Rome 5
San Francisco 5
Shenyang 5
Bergamo 4
Changsha 4
Falkenstein 4
Pescara 4
Turin 4
Wroclaw 4
Athens 3
Brooklyn 3
Chicago 3
Chiswick 3
Dearborn 3
Florence 3
Hebei 3
Jiaxing 3
Kocaeli 3
Lappeenranta 3
Leawood 3
Melbourne 3
Redwood City 3
Tianjin 3
Viterbo 3
Bucaramanga 2
Casanova Lonati 2
Cetraro 2
Core 2
Guangzhou 2
Haikou 2
Halifax 2
Lovere 2
Mazzano 2
Montesilvano Marina 2
Mumbai 2
Ningbo 2
Palermo 2
Pavia 2
Santa Clara 2
Storo 2
São Paulo 2
Verdellino 2
Amsterdam 1
Ancona 1
Aosta 1
Augusta 1
Bangkok 1
Bogotá 1
Borås 1
Boston 1
Cachan 1
Castiglione Delle Stiviere 1
Centurion 1
Civitavecchia 1
Colombo 1
Cremona 1
Darfo 1
Fiesole 1
Fiorenzuola D'arda 1
Gossolengo 1
Hangzhou 1
Hanover 1
Hillsborough 1
Hounslow 1
Kilburn 1
Totale 1.743
Nome #
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 120
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 118
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 107
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 106
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 98
The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era 90
A Case of Spondyloarthritis in Patient Affected by Unicentric Castleman's Disease Effectively Managed with Surgery Resection and Tocilizumab Treatment 83
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 81
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 80
Advances in CMV Management: A Single Center Real-Life Experience 78
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 68
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 66
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 66
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 63
Successful hematopoietic stem cell transplantation for complete CTLA-4 haploinsufficiency due to a de novo monoallelic 2q33.2-2q33.3 deletion 59
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 56
PS1540 MULTIPARAMETRIC PREDICTIVE SCORE FOR GRAFT VERSUS HOST DISEASE (GVHD) IN PATIENTS SUBMITTED TO ALLOGENEIC STEM CELLS TRANSPLANTATION (SCT) 56
Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line? 55
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 54
ANTI-CMV IMMUNOGLOBULINS IN ASSOCIATION WITH ANTI-CMV DRUGS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION: A MULTI-CENTRE RETROSPECTIVE EXPERIENCE 51
Allogeneic transplantation for patient with myelodisplastic sindromes: a single centre experience 50
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 48
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 48
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 47
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 45
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: results from a retrospective multicentre study 43
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 43
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 40
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 40
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 33
A Systematic Review of the Literature and Perspectives on the Role of Biomarkers in the Management of Malnutrition After Allogeneic Hematopoietic Stem Cell Transplantation 31
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 29
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 27
Management of invasive infections due to a rare arthroconidial yeast, saprochaete capitata, in two patients with acute hematological malignancies 27
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 22
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 21
Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients 20
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 19
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 18
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation 14
Pre-Emptive Donor Lymphocyte Infusion As Optimal Treatment for Relapsed Acute Myeloid Leukemias and Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation: Insights from a French-Italian Study on 134 Patients 14
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 14
Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration 13
Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study 13
PB1959: BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY 13
Nutritional strategies to improve VRE control 11
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 9
MALNUTRITION AND GVHD IN ALLOGENIC BONE MARROW TRANSPLANTATION: A PROSPECTIVE STUDY 9
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation (Bone Marrow Transplantation, (2023), 10.1038/s41409-023-02124-y) 9
Totale 2.325
Categoria #
all - tutte 16.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.266


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020347 0 0 8 29 28 38 32 35 47 70 24 36
2020/2021489 13 28 13 85 22 63 32 49 44 79 35 26
2021/2022293 25 17 5 26 8 25 12 27 13 51 20 64
2022/2023382 44 11 17 36 35 79 2 44 44 12 28 30
2023/2024612 32 14 51 34 33 145 27 24 100 9 17 126
2024/202594 40 54 0 0 0 0 0 0 0 0 0 0
Totale 2.325